Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 176

1.

High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment.

Furuzawa-Carballeda J, Lima G, Uribe-Uribe N, Avila-Casado C, Mancilla E, Morales-Buenrostro LE, Pérez-Garrido J, Pérez M, Cárdenas G, Llorente L, Alberú J.

Transplant Proc. 2010 Nov;42(9):3489-96. doi: 10.1016/j.transproceed.2010.08.037.

PMID:
21094802
2.

Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment.

Furuzawa-Carballeda J, Bostock IC, Lima G, Mancilla-Urrea E, Mondragón G, Reyes-Acevedo R, Chevaile A, Morales-Buenrostro LE, Llorente L, Alberú J.

Transpl Immunol. 2014 Mar;30(2-3):107-13. doi: 10.1016/j.trim.2014.02.002. Epub 2014 Feb 18.

PMID:
24561014
3.

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade.

Chavez H, Beaudreuil S, Abbed K, Taoufic Y, Kriaa F, Charpentier B, Durrbach A.

Transpl Immunol. 2007 Jun;17(4):243-8. Epub 2007 Jan 24.

PMID:
17493526
4.

Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study.

Furuzawa-Carballeda J, Lima G, Jakez-Ocampo J, Llorente L.

Eur J Clin Invest. 2011 Oct;41(10):1037-46. doi: 10.1111/j.1365-2362.2011.02491.x. Epub 2011 Mar 2.

PMID:
21366559
5.

Infiltrating cellular pattern in kidney graft biopsies translates into forkhead box protein 3 up-regulation and p16INK4α senescence protein down-regulation in patients treated with belatacept compared to cyclosporin A.

Furuzawa-Carballeda J, Lima G, Alberú J, Palafox D, Uribe-Uribe N, Morales-Buenrostro LE, Reyes Acevedo R, Mondragón G, Chevaile A, Llorente L.

Clin Exp Immunol. 2012 Feb;167(2):330-7. doi: 10.1111/j.1365-2249.2011.04504.x.

6.

T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.

Grimbert P, Audard V, Diet C, Matignon M, Plonquet A, Mansour H, Desvaux D, Durrbach A, Cohen JL, Lang P.

Nephrol Dial Transplant. 2011 Mar;26(3):1087-93. doi: 10.1093/ndt/gfq453. Epub 2010 Jul 28.

PMID:
20667993
7.

Indoleamine 2,3-dioxygenase affects the aggressiveness of intraductal papillary mucinous neoplasms through Foxp3+CD4+CD25+ T cells in peripheral blood.

Ikemoto T, Shimada M, Komatsu M, Yamada S, Saito Y, Mori H, Morine Y, Imura S, Bando Y, Utsunomiya T.

Pancreas. 2013 Jan;42(1):130-4. doi: 10.1097/MPA.0b013e3182575e4a.

PMID:
22722263
8.

Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients.

Chu ZQ, Ji Q.

Transplant Proc. 2013 Jan-Feb;45(1):153-6. doi: 10.1016/j.transproceed.2012.07.145.

PMID:
23375290
9.

Foxp3+ T cells in peripheral blood of renal transplant recipients and clinical correlations.

Lin WX, Christiansen D, Fu LL, Roberts MA, Sandrin MS, Ierino FL.

Nephrology (Carlton). 2012 May;17(4):415-22. doi: 10.1111/j.1440-1797.2012.01578.x.

PMID:
22308996
10.

Upregulated expression of indoleamine 2, 3-dioxygenase in CHO cells induces apoptosis of competent T cells and increases proportion of Treg cells.

Sun J, Yu J, Li H, Yang L, Wei F, Yu W, Liu J, Ren X.

J Exp Clin Cancer Res. 2011 Sep 14;30:82. doi: 10.1186/1756-9966-30-82.

11.

Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.

Calvo-Turrubiartes M, Romano-Moreno S, García-Hernández M, Chevaile-Ramos JA, Layseca-Espinosa E, González-Amaro R, Portales-Pérez D.

Transpl Immunol. 2009 May;21(1):43-9. doi: 10.1016/j.trim.2009.02.002. Epub 2009 Feb 20.

PMID:
19233271
12.

Indoleamine 2,3-dioxygenase: expressing cells in inflammatory bowel disease-a cross-sectional study.

Furuzawa-Carballeda J, Fonseca-Camarillo G, Lima G, Yamamoto-Furusho JK.

Clin Dev Immunol. 2013;2013:278035. doi: 10.1155/2013/278035. Epub 2013 Oct 27.

13.

Belatacept in kidney transplantation.

Wojciechowski D, Vincenti F.

Curr Opin Organ Transplant. 2012 Dec;17(6):640-7. doi: 10.1097/MOT.0b013e32835a4c0d. Review.

PMID:
23044530
14.

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.

Segundo DS, Ruiz JC, Izquierdo M, Fernández-Fresnedo G, Gómez-Alamillo C, Merino R, Benito MJ, Cacho E, Rodrigo E, Palomar R, López-Hoyos M, Arias M.

Transplantation. 2006 Aug 27;82(4):550-7.

PMID:
16926600
15.

Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study.

Zhao T, Yang C, Qiu Y, Xue Y, Zhao Z, Song D, Qiu Y, Ma Z, Yang B, Xu M, Rong R, Zhu T.

Transplant Proc. 2013 Jan-Feb;45(1):148-52. doi: 10.1016/j.transproceed.2012.06.067.

PMID:
23375289
16.

Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs.

Bocian K, Borysowski J, Wierzbicki P, Wyzgal J, Klosowska D, Bialoszewska A, Paczek L, Górski A, Korczak-Kowalska G.

Nephrol Dial Transplant. 2010 Mar;25(3):710-7. doi: 10.1093/ndt/gfp586. Epub 2009 Nov 9.

PMID:
19903662
17.

Different immunosuppressive combinations on T-cell regulation in renal transplant recipients.

Fourtounas C, Dousdampanis P, Sakellaraki P, Rodi M, Georgakopoulos T, Vlachojannis JG, Mouzaki A.

Am J Nephrol. 2010;32(1):1-9. doi: 10.1159/000313940. Epub 2010 May 20.

PMID:
20484893
18.

Indoleamine 2,3-dioxygenase, a new prognostic marker in sentinel lymph nodes of melanoma patients.

Speeckaert R, Vermaelen K, van Geel N, Autier P, Lambert J, Haspeslagh M, van Gele M, Thielemans K, Neyns B, Roche N, Verbeke N, Deron P, Speeckaert M, Brochez L.

Eur J Cancer. 2012 Sep;48(13):2004-11. doi: 10.1016/j.ejca.2011.09.007. Epub 2011 Oct 25.

PMID:
22033321
19.

Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts.

Hautz T, Brandacher G, Zelger B, Müller HG, Lee AW, Fuchs D, Margreiter R, Schneeberger S.

Transplant Proc. 2009 Mar;41(2):509-12. doi: 10.1016/j.transproceed.2009.01.008.

PMID:
19328914
20.

Decreased frequency of peripheral CD4(+) CD161(+) Th(17) -precursor cells in kidney transplant recipients on long-term therapy with Belatacept.

Vondran FW, Timrott K, Kollrich S, Klempnauer J, Schwinzer R, Becker T.

Transpl Int. 2012 Apr;25(4):455-63. doi: 10.1111/j.1432-2277.2012.01441.x. Epub 2012 Feb 20. Erratum in: Transpl Int. 2012 Oct;25(10):1117.

Supplemental Content

Support Center